At Solid Drug Development, we have always striven to put our stamp of quality and efficiency on every project that we undertake.  Our Team has successfully completed more than a 100 projects in all geographies, clinical fields and company sizes. These include :

• more than 25 leads produced in GMPs conditions,
• more than 100 preclinical studies,
• more than 37 clinical studies from Phase I to Phase III,
• 11 products registered with EMA / FDA / ASIA.

Our experimental and innovative approach has also resulted in the :

• first topical use of an antibody (WW Patents),
• locoregional use of a Jnk-inhibitor.